Using Advanced MR Imaging to Determine High Risk Areas in Patients With Malignant High Grade Gliomas and to Design Potential Radiation Plans
Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Single Blind (Investigator), Primary Purpose: Diagnostic
To assess the utility of baseline advanced MRI & changes between baseline & follow up advanced MRI in predicting high risk areas that are likely to develop progressive glioma despite chemoradiotherapy.
1 -7 weeks before radiation treatment, about two months after treatment, and about every two months thereafter for the duration of the study.
Robert Young, MD
Memorial Sloan-Kettering Cancer Center
United States: Institutional Review Board
|Memorial Sloan-Kettering Cancer Center||New York, New York 10021|